Electromyographic control of botulinum toxin a injections in the upper extremities in patients with spasticity of various etiology

Akulov M.A.; Orlova O.R.; Khat’kova S.E.; Usachev D.Iu.; Zakharov V.O.; Tomskiĭ A.A.; Orlova A.S.

doi:https://doi.org/10.17116/neiro201579638-45

Akulov M.A.

FGBNU "NII neĭrokhirurgii im. akad. N.N. Burdenko" RAMN, Moskva

Orlova O.R.

Moskovskiĭ nauchno-prakticheskiĭ Tsentr dermatovenerologii i kosmetologii Departamenta zdravookhraneniia Moskvy, 119071, Moskva, Rossiĭskaia Federatsiia

SPIN RSCI: 9007-4907
Scopus AuthorID: 7006342537
ORCID: 0000-0003-2225-3642

Khat’kova S.E.

Federal state budgetary institution «Medical and Rehabilitation Center», Moscow

Usachev D.Iu.

NII neĭrokhirurgii im. akad. N.N. Burdenko RAMN, Moskva

Zakharov V.O.

FGBNU "NII neĭrokhirurgii im. akad. N.N. Burdenko" RAMN, Moskva

Tomskiĭ A.A.

FGBU "NII neĭrokhirurgii im. N.N. Burdenko" RAMN, Moskva

Orlova A.S.

I.M. Sechenov First Moscow State Medical University, Moscow

Electromyographic control of botulinum toxin a injections in the upper extremities in patients with spasticity of various etiology

Authors:

Akulov M.A., Orlova O.R., Khat’kova S.E., Usachev D.Iu., Zakharov V.O., Tomskiĭ A.A., Orlova A.S.

More about the authors

Journal: Burdenko's Journal of Neurosurgery. 2015;79(6): 38‑45

DOI: 10.17116/neiro201579638-45

Read: 3113 times

To cite this article:

Akulov MA, Orlova OR, Khat’kova SE, Usachev DIu, Zakharov VO, Tomskiĭ AA, Orlova AS. Electromyographic control of botulinum toxin a injections in the upper extremities in patients with spasticity of various etiology. Burdenko's Journal of Neurosurgery. 2015;79(6):38‑45. (In Russ., In Engl.)
https://doi.org/10.17116/neiro201579638-45

Подписка 2025 Журнал «Вопросы нейрохирургии» имени Н.Н. Бурденко (Burdenko's Journal of Neurosurgery)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Effectiveness of muscles’ preoperative preparation for reconstruction of anterior cruciate ligament of knee. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(1):51-57

Cocarnit in complex therapy of diabetic peripheral polyneuropathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):73-81

Significance of dystonic tremor as a possible predictor of depression in patients with cervical dystonia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):37-41

Characteristics of the functional state of the masticatory muscles in patients with hemifacial microsomy at the stages of complex treatment. Stomatology. 2025;(5):29-36

Electromyographic evaluation of the dynamic electroneurostimulation effectiveness in skeletal class III patient rehabilitation after orthognathic surgery. Stomatology. 2025;(6):43-48

Modern concepts of the blood supply to the frontalis muscle: anatomy, clinical aspects, and significance. Russian Journal of Operative Surgery and Clinical Anatomy. 2025;(4):60-67

Experience of Relatox (botulinum toxin type A) using for chronic migraine treatment. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(12):134-140

The use of botulinum toxin in ventral hernia repair. Endoscopic Surgery. 2026;(1):68-73

Botulinum toxin type A reducing extent of TAR procedure in patients with large postoperative hernias. Pirogov Russian Journal of Surgery. 2026;(2):85-92

Abstract:

Aim. The study was aimed at studying the efficacy of botulinum toxin A injections combined with EMG-control of the injections in patients with upper limb spasticity of various etiology for decreasing muscle tone and improving the passive limb function as well as at assessing the possibility of a botulinum toxin dose reduction under combination of these methods. Material and methods. 61 patients with upper limb spasticity of different etiology were evaluated. The main group consisted of 29 patients who were injected with abobotulinum, the botulinum toxin A (500 U per vial), under EMG-control. The control group consisted of 32 patients who received BTA injections without EMG-control. A repeated BTA injection was performed on the 4th month of the study. Patients in both groups received standard rehabilitation therapy. The spasticity pattern was determined using the Arm Spasticity Pattern (ASP) scale. Evaluation of the treatment efficacy was performed using the modified Ashworth scale to determine upper limb spasticity and the modified Barthel Index scale to assess the quality of life as well as the Disability Assessment Scale (DAS) and Clinical Global Impression (CGI) scale. Results. The main spasticity patterns were as follows: the type III was in 13 (44.8%) and 17 (53.1%) patients, the type I was in 9 (31.0%) and 9 (28.1%) patients, and the type VI was in 7 (24.2%) and 6 (18.8%) patients of the main and control groups, respectively. One month after BTA treatment, a significant improvement was observed in both groups, but the improvement in the main group was more pronounced compared to that in the control group (р<0.05). This difference persisted for the whole treatment period (р<0.05). The DAS score demonstrated improvement in both groups, but only patients of the main group had a statistically significant improvement in putting the arm through a sleeve (р<0.05). EMG-control enabled a reduction in the BTA dose by 50―300 U. Conclusions. BTA injections under EMG-control in upper limb spasticity patients may improve the treatment efficacy.

Keywords:

upper limb spasticity

botulinum toxin

electromyography

Authors:

Akulov M.A.

FGBNU "NII neĭrokhirurgii im. akad. N.N. Burdenko" RAMN, Moskva

Orlova O.R.

Moskovskiĭ nauchno-prakticheskiĭ Tsentr dermatovenerologii i kosmetologii Departamenta zdravookhraneniia Moskvy, 119071, Moskva, Rossiĭskaia Federatsiia

SPIN RSCI: 9007-4907
Scopus AuthorID: 7006342537
ORCID: 0000-0003-2225-3642

Khat’kova S.E.

Federal state budgetary institution «Medical and Rehabilitation Center», Moscow

Usachev D.Iu.

NII neĭrokhirurgii im. akad. N.N. Burdenko RAMN, Moskva

Zakharov V.O.

FGBNU "NII neĭrokhirurgii im. akad. N.N. Burdenko" RAMN, Moskva

Tomskiĭ A.A.

FGBU "NII neĭrokhirurgii im. N.N. Burdenko" RAMN, Moskva

Orlova A.S.

I.M. Sechenov First Moscow State Medical University, Moscow

Close metadata

References:

Khat’kova S, Timerbaeva S, Orlova O, Poznyakova E. The profile of adult patients with upper limb muscle spasticity treated by the botulinum toxin type A (an international survey). Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(8):23-26. (In Russ.).
Santamato A, Micello MF, Ranieri M, Valeno G, Albano A, Baricich A, Cisari C, Intiso D, Pilotto A, Logroscino G, Panza F. Employment of higher doses of botulinum toxin type A to reduce spasticity after stroke. J Neurol Sci. 2015;15:350(1-2):1-6.
Martin A, Abogunrin S, Kurth H, Dinet J. Epidemiological, humanistic, and economic burden of illness of lower limb spasticity in adults: a systematic review. Neuropsychiatr Dis Treat 2014;23:10:111-122. doi:10.2147/NDT.S53913.
Khat’kova S, Orlova O, Timerbaeva S. The clinical profile of patients with spasticity of the upper limb treated by the botulinum toxin type A (an international survey). Vrach. 2011;5:70-73. (In Russ.).
Kinnear BZ, Lannin NA, Cusick A, Harvey LA, Rawicki B. Rehabilitation therapies after botulinum toxin-A injection to manage limb spasticity: a systematic review. Phys Ther. 2014;94(11):1569-1581. doi:10.2522/ptj.20130408.
Lim EC, Seet RC. Botulinum toxin: description of injection techniques and examination of controversies surrounding toxin diffusion. Acta Neurologica Scandinavica. 2008;117:73-84. doi:10.1111/j.1600-0404.2007.00931.x.
Kotlyarov V, Khat’kova S, Orlova O, Timerbaeva S. Control of physiotherapeutic myostimulation and botulinum toxin injections in patients with poststroke spasticity. Vrach. 2011;10:68-70. (In Russ.).
Childers MK. The importance of electromyographic guidance and electrical stimulation for injection of botulinum toxin. Phys Med Rehabil Clin N Am. 2003;14:781-792. doi:10.1016/S1047-9651(03)00047-0.
Khat’kova S. Guidelines for the use of dysport in upper limb spasticity after stroke. Federal Supervisory Agency for Health Care and Social Development. No. FS 2006/379-U of 28.12.2006. Moscow 2006. (In Russ.).
Khat’kova S. The use of botulinum toxin type A (dysport) in comprehensive therapy of patients with poststroke spasticity. Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(8):23-26. (In Russ.).
Khat’kova S, Koneva E, Sidyakina I. Comprehensive rehabilitation of patients with poststroke hand spasticity: guidelines for doctors. Moscow: Medical and Rehabilitation Center; 2011. (In Russ.).
Wissel J, Ward A.B, Erztgaard P, Bensmail D, Hecht MJ, Lejeune TM, Schnider P, Altavista MC, Cavazza S, Deltombe T, Duarte E, Geurts AC, Gracies JM, Haboubi NH, Juan FJ, Kasch H, Kätterer C, Kirazli Y, Manganotti P, Parman Y, Paternostro-Sluga T, Petropoulou K, Prempeh R, Rousseaux M, Slawek J, Tieranta N. European consensus table on the use of botulinum toxin type A in adult spasticity. J Rehabil Med. 2009;41(1):13-25. doi: 10.2340/16501977-0303.
Turner-Stockes L. Goal attainment scaling (GAS) in rehabilitation: a practice guide. Clinical Rehabilitation. 2009;23(4):362-370. doi: 10.1177/0269215508101742.
Ward AB. Handbook of the management of adult spasticity course. Stoke on Trent. 2008.
Timerbaeva S. The alphabet of botulinotheraphy. Moscow: Prakticheskaya meditsina; 2014. (In Russ.).
Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Physical Therapy. 1987;67:206-207.
Loewen SC, Anderson BA. Predictors of stroke outcome using objective measurement scales. Stroke. 1990;21:78-81.
Jette A, Clearly P. Functional Disability Assessment. Fhysical Therapy. 1987;67:1854-1859.
Guy W. Clinical Global Impressions (CGI) Scale. Modified From: Rush J, et al. Psychiatric Measures. APA, Washington DC. 2000.
Monnier G, Parratte B, Tatu L, Cosson A, Michel F, Metton G. EMG support in botulinum toxin treatment. Ann Readapt Med Phys. 2003;46:380-385. doi:10.1016/S0168-6054(03)00102-8.
Schroeder AS, Berweck S, Lee SH, Heinen F. Botulinum toxin treatment of children with cerebral palsy – a short review of different injection techniques. Neurotox Res. 2006;9:189-196. doi:10.1007/BF03033938.
Gracies JM, Lugassy M, Weisz DJ, Vecchio M, Flanagan S, Simpson DM. Botulinum toxin dilution and endplate targeting in spasticity: a double-blind controlled study. Arch Phys Med Rehabil. 2009;90:9-16. doi:10.1016/j.apmr.2008.04.030.
Ward AB, Aguilar M, De Beyl Z, Gedin S, Kanovsky P, Molteni F, Wissel J, Yakovleff A. Use of botulinum toxin type A in management of adult spasticity. A European consensus statement. J Rehabil Med. 2003;35:1-2. doi:10.1080/16501970306112.
Jankovic J. Needle EMG guidance for injection of botulinum toxin. Needle EMG guidance is rarely required. Muscle Nerve. 2001;24:1568-1570. doi:10.1002/mus.1186.